Back
Oncostratifier: Stratifying Oncogene-addicted Cohorts By Drug Response
Tepeli, Y. I.; Trastulla, L.; Goncalves, J. P.; Iorio, F.
2025-05-07
cancer biology
10.1101/2025.05.01.650955
bioRxiv
Show abstract
Withdrawal StatementThe authors have withdrawn this manuscript because of a disagreement between authors regarding the work. Therefore, the authors do not wish this work to be cited as reference for the project. If you have any questions, please contact the corresponding author.
Matching journals
●Non-profit
◐University press
○Commercial
The top 9 journals account for 50% of the predicted probability mass.
1
Cancers
○
213 papers in training set
Top 0.1%
18.3%
Similar papers in this journal
- Computational modeling of drug response identifies mutant-specific constraints for dosing panRAF and MEK inhibitors in melanoma 94%
- Trends in Phase II trials for cancer therapies 93%
- Casein kinase 1D encodes a novel drug target in Hedgehog-GLI driven cancers and tumor-initiating cells resistant to SMO inhibition 93%
3
Molecular Cancer Therapeutics
●
40 papers in training set
Top 0.1%
5.4%
Similar papers in this journal
- Clinical positioning of the IAP antagonist tolinapant (ASTX660) in colorectal cancer 93%
- Ovarian cancers with low CIP2A tumor expression constitute an APR-246 sensitive disease subtype 92%
- Anticancer efficacy of KRASG12C inhibitors is potentiated by PAK4 inhibitor KPT9274 in preclinical models of KRASG12C mutant pancreatic and lung cancers 92%
4
Genome Medicine
○
183 papers in training set
Top 1%
4.0%
Similar papers in this journal
- Personalized Cancer Therapy Prioritization Based on Driver Alteration Co-occurrence Patterns 96%
- Beyondcell: targeting cancer therapeutic heterogeneity in single-cell RNA-seq 95%
- Single cell lineage tracing reveals subclonal dynamics of anti-EGFR therapy resistance in triple negative breast cancer. 91%
5
npj Precision Oncology
○
53 papers in training set
Top 0.4%
4.0%
Similar papers in this journal
- Criteria-based curation of a therapy-focused compendium to support treatment recommendations in precision oncology 94%
- Overcoming Resistance to BRAFV600E Inhibition in Melanoma by Deciphering and Targeting Personalized Protein Network Alterations 94%
- TKI Type Switching Overcomes ROS1 L2086F in ROS1 Fusion-Positive Cancers 93%
50% of probability mass above
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.